Airway Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Supraglottic, Infraglottic, Resuscitators, Laryngoscopes, Others), By Application (Anesthesia, Emergency Medicine, Others), By End Use (Hospitals, Homecare, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.38 Billion
CAGR (2026-2031)	7.37%
Fastest Growing Segment	Supraglottic
Largest Market	North America
Market Size (2031)	USD 5.18 Billion

Market Overview

The Global Airway Management Devices Market is projected to grow from USD 3.38 Billion in 2025 to USD 5.18 Billion by 2031 at a 7.37% CAGR. Airway management devices are essential medical instruments designed to establish and maintain a patent airway, critical for effective ventilation and oxygenation during surgical procedures, critical care interventions, and emergency medical situations. The market's expansion is fundamentally driven by the increasing global prevalence of chronic respiratory diseases, a rising volume of surgical procedures requiring anesthesia, and the growing geriatric population often needing respiratory support.

Further market support comes from an elevated focus on enhancing emergency medical services and pre-hospital care capabilities. A significant challenge impeding market growth, however, is the substantial cost associated with advanced airway management technologies, potentially limiting their broad adoption in diverse healthcare settings. According to a June 2025 report by WHO/Europe and the European Respiratory Society, chronic respiratory diseases affect 81.7 million people in the WHO European Region, illustrating a key demand driver for these devices.

Key Market Drivers

The Global Airway Management Devices Market is significantly propelled by the rising prevalence of chronic respiratory diseases worldwide. These conditions necessitate effective airway management to ensure adequate ventilation and oxygenation for affected individuals. For instance, according to the Global Burden of Disease 2023 study published in Nature Medicine, January 2026, nearly 570 million people worldwide were living with a chronic respiratory disease in 2023. This substantial patient population drives ongoing demand for a range of devices, including endotracheal tubes, laryngeal mask airways, and ventilators, essential for both acute and long-term respiratory support.

Concurrently, the increasing volume of surgical procedures serves as a pivotal driving force for market expansion, as most surgeries require precise airway control for anesthesia administration. The Lancet, as reported by Wits University in September 2025, indicated that the unmet need for surgical procedures has escalated to 160 million annually, highlighting a persistent and extensive demand for surgical interventions. This consistent need for safe and effective anesthesia care directly translates to a heightened utilization of airway management devices in operating rooms globally. Supporting overall market development, the WFSA Annual Report, February 2026, noted that in 2025, the organization expanded its capacity-building work in anesthesia education, reaching clinicians across more than 80 countries.

Download Free Sample Report

Key Market Challenges

The substantial cost associated with advanced airway management technologies directly impedes the growth of the global airway management devices market. High acquisition prices for these sophisticated instruments and their associated consumables strain healthcare budgets, particularly in regions with limited financial resources or underdeveloped healthcare infrastructures. This financial barrier often forces healthcare providers to prioritize less expensive, potentially less effective, alternatives or delay upgrades to newer, more advanced systems. The resulting restricted access to these critical devices can compromise patient care outcomes and hinder the market's expansion into untapped segments.

The budgetary constraints further exacerbate adoption challenges, even for essential equipment. According to the American Hospital Association's 2026 Environmental Scan, published in December 2025, 94% of hospital administrators planned to delay equipment upgrades due to financial strain. This indicates a direct pressure on procurement decisions for high-value medical equipment, including specialized airway management tools. Such financial limitations not only slow down the rate of new device integration but also limit the volume of sales, as healthcare facilities are often compelled to extend the lifespan of older equipment or procure fewer units than clinically optimal, directly curtailing market potential.

Key Market Trends

A significant trend transforming the global airway management devices market is the increasing shift towards non-invasive and minimally invasive solutions. This progression is driven by the desire to minimize patient discomfort and trauma, reduce recovery times, and lower the risk of complications associated with traditional invasive procedures. Innovations in design and materials contribute to the development of devices that provide effective airway control with less invasive profiles, such as advanced supraglottic airways and specialized bronchoscopes. For instance, according to Investing.com, in February 2026, Ambu A/S reported an 8.3% organic growth in its Respiratory segment during the first quarter of fiscal year 2025/26, a growth attributed to its bronchoscopy portfolio and the launch of the SureSight™ Mobile video laryngoscope.

Concurrently, the integration of digital technologies and advanced monitoring systems is critically reshaping the market. These innovations enable real-time data acquisition, enhanced visualization, and improved decision-making capabilities for healthcare professionals. Connected devices offer features such as remote patient monitoring, predictive analytics, and artificial intelligence-powered support, which are vital for managing complex respiratory conditions and optimizing device performance. This technological convergence is paving the way for more precise and personalized airway management. As reported by HME News in February 2026, Philips' Connected Care segment, encompassing Sleep and Respiratory Care, experienced a 7% increase in comparable sales during the fourth quarter of 2025.

Segmental Insights

The Supraglottic segment is recognized as the fastest-growing category within the Global Airway Management Devices Market. This rapid expansion is primarily attributed to the inherent advantages these devices offer, including their ease and speed of insertion, which is critical in both elective surgical procedures and emergent clinical situations. Supraglottic airways are associated with reduced patient trauma and fewer complications compared to traditional intubation methods, thus enhancing patient safety and comfort. Continuous advancements in device technology, improving design and functionality, alongside the increasing global volume of surgical interventions and a growing preference for less invasive airway solutions, significantly contribute to their widespread adoption. Furthermore, favorable clinical guidelines from professional bodies, such as the American Society of Anesthesiologists, support the expanded utilization of supraglottic devices in modern medical practice.

Regional Insights

North America leads the global airway management devices market due to its advanced healthcare infrastructure and substantial investment in medical technologies. The region exhibits a high prevalence of chronic respiratory diseases and a consistently increasing volume of surgical procedures, driving demand for these devices. Furthermore, the rapid adoption of technologically advanced airway management systems, coupled with favorable regulatory frameworks established by bodies such as the Food and Drug Administration and the American Society of Anesthesiologists, encourages market growth and innovation. This environment fosters significant research and development activities and the introduction of new products by key market players.

Recent Developments

• In March 2026, Airiver Medical, a clinical-stage company, received Breakthrough Device Designation from the U.S. Food and Drug Administration for its Pulmonary Drug Coated Balloon (DCB). This device is intended for treating central airway stenosis, with the designation aiming to expedite its development and patient access due to its potential for more effective treatment compared to existing options. The company also announced the enrollment and treatment of the first patient in its pivotal U.S. clinical trial, which will evaluate the safety and efficacy of the Airiver DCB for this condition.
• In March 2026, Airway Innovations and Medical Specialties announced an exclusive partnership. This collaboration aimed to expand the adoption of Airway Innovations’ AERIS Airway™ device. This agreement represents a strategic move to broaden the reach and utilization of the AERIS Airway™ device within the global airway management devices market. The partnership is focused on accelerating market penetration and ensuring more widespread availability of the device for patient care.
• In October 2025, Airway Management introduced the Nylon flexTAP, a pioneering 3D-printed midline oral appliance for obstructive sleep apnea (OSA). This device received clearance from the U.S. Food and Drug Administration for mild to moderate OSA, aiming to enhance patient comfort and treatment efficacy. Its design incorporates digitally printed medical-grade nylon and patented Vertex Technology, enabling dual-axis movement to maximize airway space. The Nylon flexTAP, manufactured in the United States, eliminates the requirement for bite registration, simplifying the fitting process for clinicians and patients.
• In May 2025, Apreo Health, a clinical-stage medical device company, emerged from stealth mode to present its novel BREATHE Airway Scaffold. This lung implant is designed to alleviate pressure in hyperinflated lungs associated with severe emphysema without removing or sacrificing healthy tissue. The company announced its upcoming presentation of first-in-human clinical data from its BREATHE 1&2 feasibility studies at the American Thoracic Society 2025 International Conference. In September 2025, Apreo Health also finalized an oversubscribed $130 million Series B financing round to support its pivotal trial and early commercialization efforts.

Key Market Players

• Medtronic plc
• Teleflex Incorporated
• Ambu A/S
• Smiths Group plc
• Koninklijke Philips N.V.
• Fisher & Paykel Healthcare Corporation Limited
• Drägerwerk AG & Co. KGaA
• Intersurgical Ltd.
• Vyaire Medical, Inc.
• SunMed, LLC

By Product	By Application	By End Use	By Region
Supraglottic Infraglottic Resuscitators Laryngoscopes Others	Anesthesia Emergency Medicine Others	Hospitals Homecare Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Airway Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Airway Management Devices Market, By Product:

• Supraglottic
• Infraglottic
• Resuscitators
• Laryngoscopes
• Others

• Airway Management Devices Market, By Application:

• Anesthesia
• Emergency Medicine
• Others

• Airway Management Devices Market, By End Use:

• Hospitals
• Homecare
• Others

• Airway Management Devices Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE